SAN DIEGO (PRWEB) September 27, 2019
CureMatch is pleased to announce our win at MedTech Insight Awards 2019 in the category of Best Technological Innovation: Digital. The judges explained their choice by describing the platform as “An exciting technology that has the potential to transform how cancer care is delivered. What an excellent use of data, and a well-deserved winning entry by the San-Diego based company.”
CureMatch CEO Bob Manning was in attendance to receive the honor, and said of the award, “This award represents years of effort by the entire CureMatch team. I can speak for all of us when saying that we are honored to be empowering oncologists, delivering better outcomes, and giving patients greater hope. Receiving this recognition provides further inspiration and motivation as we continue to grow, improve, and reach a wider market.”
Ramsey Hashem, CCO at Pharma Intelligence, presented the award. We extend our congratulations to the other winners, among them Johns Hopkins Medicine and Medtronic.
CureMatch, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for individual patients based on their molecular tumor profile. CureMatch enables oncologists to become experts in personalized medicine by providing them with actionable intelligence towards advanced cancer treatment options. http://www.curematch.com.